AlPage, a bit of good news for us expats living in China. Reports coming from the horse's mouth of German pharmaceutical BioNTech SE. Pending approval from local regulators, their shipment of 100 million doses to mainland China may be nigh. Initial reports of their rollout to the Chinese market was last December by Chinese drug supplier Shanghai Fosun. Red tape still needs to be ironed out. So keep an eye out for the possible entry of BioNTech while conducting your due diligence.
As you may know, BioNTech partners with Pfizer Inc. in the development of their more advanced mRNA vaccines. Based on aggregate data, over 90% efficacy (after two doses).
Presumably higher efficacy and safety based on data with more elders given the jab compared to the age restricted, incomplete/inconsistent data of Chinese vaccine counterparts.
Link to recent CaixinGlobal interview with Ugur Sahin, CEO and co-founder of BioNTech SE:
1. People are now not required to put on masks in open, outdoor spaces.
2. Regarding designated hotels for quarantine in Kunming. Foreigners have to pay for the costs out of own pocket. Even overseas Chinese who've recently returned have to bear the burden of 14-day accommodation fees.